SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?


To: Harold Engstrom who wrote (677)6/22/1998 7:17:00 PM
From: Hong-Lee Yu  Read Replies (1) | Respond to of 1686
 
Harold,

Did management mention what they are going to do with their money ?

I also think that Avonex sales in Q2 could reach 85M, given that European sales in Q2 increased by 5.5M (the annual run-rate for Q2 is 75M). Biogen should beat expectation easily with quarterly sales of 85M in Avonex (probably in 43C - 44C ).

Thanks for your summary.

Hong-Lee